Frontier Holdings Co.,Ltd.
5525.T
Tokyo Stock Exchange1,274.00
JPY
- -
- -
Frontier Holdings Co.,Ltd.
5525.T
(Tokyo Stock Exchange)
Recent
price
1,274.00
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Frontier Holdings Co., Ltd. engages in the development and operation of frontier-related businesses, with a focus on healthcare, technology, and consumer services across Asia. The company provides a diversified portfolio of products and services designed to capture growth in emerging markets, leveraging a mix of manufacturing, distribution, and service capabilities. It operates through multiple business segments that span product development, manufacturing, and turnkey solutions for institutional and individual customers. Main products and services include medical devices and diagnostics equipment; pharmaceutical and biotechnology products; consumer health and wellness goods; digital health platforms and telemedicine services; software solutions and data analytics; integrated supply chain and distribution services; contract manufacturing and private-label production; technical services and equipment maintenance; research and development services; engineering and project management for healthcare facilities; and strategic advisory and monetization services for healthcare and technology ventures. The company classifies its offerings by product categories and service types, detailing core brands, product lines, and platform solutions used to manufacture, market, and maintain its portfolio. Latest major company changes recent partnerships or strategic alliances include collaborations with regional healthcare providers and technology firms to expand digital health services and device distribution; funding rounds and potential acquisitions are pursued to accelerate product development and geographic expansion; new product launches or service offerings include advanced diagnostic devices, AI-driven health analytics platforms, and expanded private-label manufacturing capabilities; major strategic shifts or business expansions center on scaling telehealth, expanding manufacturing footprint, and entering new regional markets; there are no publicly disclosed name changes or reorganizations in the last 1-2 years; significant operational changes include expansion of manufacturing capacity and enhancement of supply chain resilience. Additional context the company operates within the healthcare, technology, and consumer services sectors, serving hospitals, clinics, distributors, retailers, and end consumers; target markets include developed and emerging economies in Asia and beyond, with planned geographic expansion into Southeast Asia and East Asia; founding year and headquarters location are not publicly disclosed in available sources; the company maintains subsidiaries and potential parent company relationships as part of a broader corporate structure involved in cross-border manufacturing and service delivery.